bismuth has been researched along with Experimental Mammary Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Li, B; Li, Y; Liu, J; Miao, Y; Ouyang, R; Qin, X; Sun, Y; Xu, Y; Zhang, J | 1 |
| Cui, C; Guo, Z; Jia, M; Liu, Y; Ma, K; Wang, D; Wang, L; Xu, P; Zheng, K; Zhou, H | 1 |
| Chen, S; Fan, H; Sun, J; Wei, D; Zeng, L; Zhang, Y; Zhao, H; Zhu, Y | 1 |
| Chen, C; Gu, Z; Hu, Z; Liu, J; Liu, Y; Tian, G; Wang, L; Yan, L; Yin, W; Zhao, Y; Zheng, X; Zhou, L | 1 |
| Apostolidis, C; Esaias, C; Hobbs, RF; Huso, DL; Morgenstern, A; Sgouros, G; Song, H; Vajravelu, R | 1 |
| Bruchertseifer, F; Lingappa, M; Morgenstern, A; Sgouros, G; Song, H; Thompson, S | 1 |
| Akabani, G; Kennel, SJ; Zalutsky, MR | 1 |
| Brechbiel, MW; Kelly, MP; Lee, FT; Scott, AM; Smyth, FE; Tahtis, K | 1 |
| Kennel, SJ; Mirzadeh, S | 1 |
| Branning, J; Davis, IA; Kabalka, GW; Kennel, SJ; Pan, H; Paulus, MJ | 1 |
| Boll, RA; Davis, IA; Foote, LJ; Kennel, SJ; Lankford, TK; Mirzadeh, S | 1 |
| Adam, C; Apostolidis, C; Becker, I; Becker, KF; Fischer, K; Huber, R; Kremmer, E; Miederer, M; Nikula, TK; Schuhmacher, C; Schwaiger, M; Seidl, C; Senekowitsch-Schmidtke, R | 1 |
12 other study(ies) available for bismuth and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Ultrafast Synthesizing Bismuth Mesoporous Nanolitchi Radiosensitizer Loading High Dose DOX for CT-Guided Enhanced Chemoradiotherapy.
Topics: Animals; Bismuth; Cell Line, Tumor; Chemoradiotherapy; Doxorubicin; Drug Carriers; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanostructures; Porosity; Radiation-Sensitizing Agents; Tomography, X-Ray Computed | 2019 |
CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.
Topics: A549 Cells; Animals; Antineoplastic Agents; Bismuth; CD47 Antigen; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Infrared Rays; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Organoselenium Compounds; Particle Size; Phagocytosis; Photochemotherapy; Selenium Compounds; Surface Properties; Tumor Cells, Cultured | 2019 |
A one-pot synthesis of multifunctional Bi
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Bismuth; Cell Line, Tumor; Cerium; Female; Infrared Rays; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanocomposites; Nanoparticles; NIH 3T3 Cells; Particle Size; Photosensitizing Agents; Phototherapy; Sulfides; Surface Properties | 2020 |
Bismuth sulfide nanorods as a precision nanomedicine for in vivo multimodal imaging-guided photothermal therapy of tumor.
Topics: Animals; Bismuth; Cell Line, Tumor; Male; Mammary Neoplasms, Experimental; Mice; Multimodal Imaging; Nanotubes; Photoacoustic Techniques; Phototherapy; Sulfides; Theranostic Nanomedicine; Tomography, X-Ray Computed | 2015 |
Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Immunotoxins; Isotope Labeling; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2; Tissue Distribution; Yttrium Radioisotopes | 2009 |
Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.
Topics: Alpha Particles; Animals; Bismuth; Female; Immunoconjugates; Isothiocyanates; Liposomes; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasm Metastasis; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2 | 2010 |
Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images.
Topics: Alpha Particles; Animals; Astatine; Bismuth; Cell Survival; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Radioisotopes; Radiometry; Radiotherapy Dosage; Tumor Cells, Cultured | 2003 |
Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Bismuth; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Immunoglobulin Fab Fragments; Isothiocyanates; Lewis Blood Group Antigens; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Survival Rate; Tissue Distribution; Xenograft Model Antitumor Assays | 2007 |
Vascular targeted radioimmunotherapy with 213Bi--an alpha-particle emitter.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Radioimmunotherapy; Radioisotopes; Rats; Rats, Inbred F344; Tracheal Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology.
Topics: Animals; Biophysical Phenomena; Biophysics; Bismuth; Female; Lung Neoplasms; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Radioisotopes; Tomography, X-Ray Computed | 2000 |
Combination vascular targeted and tumor targeted radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Radiopharmaceuticals; Rats; Thrombomodulin; Tissue Distribution | 1999 |
Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Bismuth; Cadherins; Female; Humans; Immunotoxins; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation; Radioimmunotherapy; Radioisotopes; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured | 2001 |